Envision Pharma Group has tapped Meg Heim as its new CEO. She replaces David Thompson, who departed to work at a cancer charity and as a partner at Biota Consulting.

Heim previously founded and led Heim Global Consulting. Prior to that, she was VP, global head of scientific engagement strategy, operations and program management at Sanofi.

“Meg has an established track record within the healthcare industry and brings with her a deep understanding of medical affairs, which will be highly complementary to the existing expertise within the business,” Envision Pharma Group executive co-chair Brian Hepburn said in a statement.